[99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference
-
Add time:08/03/2019 Source:sciencedirect.com
Introduction[99mTc]duramycin is a SPECT tracer for cell death imaging. We evaluated the impact of kit formulation, purification and species difference on the pharmacokinetic profile and cell death targeting properties of [99mTc]duramycin in order to define the optimal conditions for (pre-)clinical use.
We also recommend Trading Suppliers and Manufacturers of duramycin B (cas 132246-31-2). Pls Click Website Link as below: cas 132246-31-2 suppliers
Prev:[99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy
Next:Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Imaging of rat cerebral ischemia-reperfusion injury using99mTc-labeled duramycin08/11/2019
- Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B (cas 132246-31-2) and C, and cinnamycin as indirect inhibitors of phospholipase A208/10/2019
- The feasibility of imaging myocardial ischemic/reperfusion injury using 99mTc-labeled duramycin in a porcine model08/09/2019
- A single-step kit formulation for the 99mTc-labeling of HYNIC-Duramycin08/08/2019
- Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent 99mTc-Duramycin08/07/2019
- Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine08/06/2019
- Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy08/05/2019
- Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin08/04/2019
- [99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy08/02/2019
